Skip to main content
Book Chapter

Development of PEGylated mammalian urate oxidase as a therapy for patients with refractory gout

  • Hershfield M
  • Sundy J
  • Ganson N
  • et al.
Birkhäuser Basel, (2009), 217-227
DOI: 10.1007/978-3-7643-8679-5_13
N/ACitations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Gout is a form of arthritis caused by inflammatory crystals of monosodium urate, which deposit in joints when the plasma concentration of uric acid chronically exceeds the limit of solubility, ~7 mg/dL (0.

Cite

CITATION STYLE

APA

Hershfield, M. S., Sundy, J. S., Ganson, N. J., & Kelly, S. J. (2009). Development of PEGylated mammalian urate oxidase as a therapy for patients with refractory gout. In PEGylated Protein Drugs: Basic Science and Clinical Applications (pp. 217–227). Birkhäuser Basel. https://doi.org/10.1007/978-3-7643-8679-5_13

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free